Anavex Life Sciences Corp. Stock Analysis & AI Score
Anavex Life Sciences Corp. (AVXL) has an ST Score of 57.9 (B-), driven by its Financial Strength (A+) and held back by its Momentum (D). Analysts rate it Buy with a $11.00 price target (+708.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIAVXL Stock Price History
AVXL Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
AVXL Latest Stock News
ST Score
Anavex Life Sciences Corp. (AVXL) has an ST Score of 57.9 (B-), driven by its Financial Strength (A+) and held back by its Momentum (D). Analysts rate it Buy with a $11.00 price target (+708.8% upside).
- Strongest
- Financial StrengthA+
- Weakest
- MomentumD
All factor grades
- Financial StrengthA+
- ValuationA
- ForecastA
- ProfitabilityA-
- GrowthC-
- MomentumD
- Piotroski1/9
Press Releases
Company Contact Details
AVXL stock: frequently asked questions
What is AVXL's ST Score?
Anavex Life Sciences Corp. (AVXL) has an ST Score of 57.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AVXL a buy, hold, or sell?
Analysts rate AVXL a Buy, with a price target of $11.00 (+708.8% vs the current price). Our ST Score grades it B- (57.9/100). The ST Score is a data-driven signal, not a recommendation.
What are AVXL's factor grades?
Valuation A, Profitability A-, Financial Strength A+, Momentum D, Growth C-, Forecast A.
What is AVXL's valuation grade?
Anavex Life Sciences Corp. (AVXL) earns a valuation grade of A, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AVXL's growth grade?
Anavex Life Sciences Corp. (AVXL) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AVXL's profitability grade?
Anavex Life Sciences Corp. (AVXL) earns a profitability grade of A-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AVXL's financial strength grade?
Anavex Life Sciences Corp. (AVXL) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AVXL?
The average analyst price target for Anavex Life Sciences Corp. (AVXL) is $11.00 from 13 analysts, which is +708.8% versus the recent price of $1.36.
What is AVXL's Piotroski score?
Anavex Life Sciences Corp. (AVXL) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.